Skip to main content
Fig. 4 | Health and Quality of Life Outcomes

Fig. 4

From: Health state utility estimates for value assessments of novel treatments in Huntington’s disease: a systematic literature review

Fig. 4

Comparison of published EQ-5D index scores for patients with HD

HD = Huntington’s disease; EQ-5D = EuroQol 5-dimension; EQ-5D-5L = EuroQol 5-dimension 5-level; EQ-5D-5L = EuroQol 5-dimension 3-level; NR = not reported; TFC = total functional capacity

Note: Error bars represent 95% confidence intervals derived from reported standard deviation and sample size (size of diamond represents the sample size). Country refers to location of residence of study participants

a Range for published mean EQ-5D utility for the general US population ages 35 to 64 years [49]

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us